reimbursement

News

EU regulators back two more orphan drugs, question of pricin...

Two orphan medicines are heading towards the European market, after regulators recommended rare disease drugs from Biogen and BioMarin.

News

Sanofi to repay US government $19.8 million

Costly accounting error for Sanofi.

News

Charities unite to oppose NICE rare disease rules

MPs to discuss controversial plan in special debate.

News

After healthcare defeat, markets fear Trump's tax plans will...

Trump could use executive powers to undermine system.

News

Trump facing rebellion over healthcare reforms

Back reforms or else, says Trump.

News

Will the NHS force doctors to prescribe biosimilars?

NHS authorities could begin to use the reimbursement system as a “stick” to ensure doctors prescribe cheaper biosimilar medicines amid varied uptake in different regions.

EU regulators back two more orphan drugs, question of pricin...

Sanofi to repay US government $19.8 million

Charities unite to oppose NICE rare disease rules

After healthcare defeat, markets fear Trump's tax plans will...

Trump facing rebellion over healthcare reforms

Will the NHS force doctors to prescribe biosimilars?

Kaken details the data behind its PI3K inhibitor filing

Discover a new era of healthcare panel engagement: Grounded ...

reimbursement

Editor's Picks